What changed in this filing

/stocks — the workspaceLOADING

Item 1A. Risk Factors

2021-08-16 compared with 2021-02-12 · 31 added, 30 removed, 13 unchanged (82% of the section changed)

significant risks in our business, some of which are unknown to us and not presently foreseen.

many significant risks in our business, some of which are unknown to us and not presently foreseen.

These risks could have a material

2 unchanged sentences

risks under Item 1A of our Annual Report on Form 10-K for the year ended March 31, 2021, which we filed with the SEC on June 29,

The global outbreak

of COVID-19 was declared a pandemic by the World Health Organization and a national emergency by the U.S.

The full effects of COVID-19

and other potential future public health crises, epidemics, pandemics or similar events are uncertain and could have a material

and adverse effect on our business, financial condition, operating results and cash flows.

The global outbreak of the coronavirus

disease 2019, or COVID-19, was declared a pandemic by the World Health Organization and a national emergency by the U.S.

in March 2020.

This has negatively affected the world economy, disrupted global supply chains, significantly restricted travel

and transportation, resulted in mandated closures and orders to “shelter-in-place”

and created significant disruption

and transportation, resulted in mandated closures and orders to “shelter-in-place” and created significant disruption

of the financial markets.

1 unchanged sentence

including the duration and spread of the pandemic and related actions taken by U.S.

and foreign government agencies

to prevent disease spread, all of which are uncertain, out of our control and cannot be predicted.

complying with county and state orders and have implemented a teleworking policy for our employees and contractors and significantly

and foreign government agencies to prevent

disease spread, all of which are uncertain, out of our control and cannot be predicted.

We have been complying with county

and state orders and, until May 2021, had implemented a teleworking policy for our employees and contractors and significantly

minimized the number of employees who visit our office.

However, a facility closure, work slowdowns or temporary stoppage at our

facility or at one of our suppliers could occur, which could have a longer-term impact and could delay our product production

and delay the submission of our product for approval by the FDA and affect our ability to conduct business.

If our workforce

is unable to work effectively, including because of illness, quarantines, absenteeism, government actions, facility closure, travel

restrictions or other restrictions in connection with the COVID-19 pandemic, our operations will be negatively impacted.

be unable to develop our product, and our costs may increase as a result of the COVID-19 outbreak.

The impacts could worsen if

there is an extended duration of any COVID-19 outbreak or a resurgence of COVID-19 infection in affected regions after they have

begun to experience improvement.

We rely on other

companies to provide components and to perform services for us.

An extended period of supply chain disruption caused by the response

to COVID-19 could impact our ability to produce our initial product quantities, and, if we are not able to implement alternatives

or other mitigations, product deliveries would be adversely impacted and negatively impact our business, financial condition,

operating results and cash flows.

Limitations on government operations can also impact regulatory approvals that are necessary

for us to operate our business.

The continued

spread of COVID-19 has also led to disruption and volatility in the global capital markets.

We have been able to raise capital

in a private placement that commenced in March 2020, however, we will need to raise additional capital to support our operations

However, a facility closure, work slowdowns or temporary stoppage at one

of our manufacturing suppliers could occur, which could have a longer-term impact and could delay our prototype production and

ability to conduct business.

If our workforce is unable to work effectively, including because of illness, quarantines, absenteeism,

government actions, facility closures, travel restrictions or other restrictions in connection with the COVID-19 pandemic, our

operations will be negatively impacted.

We may be unable to develop our product, and our costs may increase as a result of the

COVID-19 outbreak.

The impacts could worsen if there is an extended duration of any COVID-19 outbreak or a resurgence of COVID-19

infection in affected regions after they have begun to experience improvement.

We rely on other companies to provide

components and to perform services for us.

An extended period of supply chain disruption caused by the response to COVID-19 could

impact our ability to produce our initial product quantities, and, if we are not able to implement alternatives or other mitigations,

product deliveries would be adversely impacted and negatively impact our business, financial condition, operating results and

Limitations on government operations can also impact regulatory approvals that are necessary for us to operate our

The continued spread of COVID-19

has also led to disruption and volatility in the global capital markets.

We were recently able to raise additional capital in

a private placement of convertible promissory notes, however, we will need to raise additional capital to support our operations

in the future.

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1A. Risk Factors